Literature DB >> 22704624

Toll-like receptor 7 is required for effective adaptive immune responses that prevent persistent virus infection.

Kevin B Walsh1, John R Teijaro, Elina I Zuniga, Megan J Welch, Daniel M Fremgen, Shawn D Blackburn, Karl F von Tiehl, E John Wherry, Richard A Flavell, Michael B A Oldstone.   

Abstract

TLR7 is an innate signaling receptor that recognizes single-stranded viral RNA and is activated by viruses that cause persistent infections. We show that TLR7 signaling dictates either clearance or establishment of life-long chronic infection by lymphocytic choriomeningitis virus (LCMV) Cl 13 but does not affect clearance of the acute LCMV Armstrong 53b strain. TLR7(-/-) mice infected with LCMV Cl 13 remained viremic throughout life from defects in the adaptive antiviral immune response-notably, diminished T cell function, exacerbated T cell exhaustion, decreased plasma cell maturation, and negligible antiviral antibody production. Adoptive transfer of TLR7(+/+) LCMV immune memory cells that enhanced clearance of persistent LCMV Cl 13 infection in TLR7(+/+) mice failed to purge LCMV Cl 13 infection in TLR7(-/-) mice, demonstrating that a TLR7-deficient environment renders antiviral responses ineffective. Therefore, methods that promote TLR7 signaling are promising treatment strategies for chronic viral infections.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22704624      PMCID: PMC3377981          DOI: 10.1016/j.chom.2012.04.016

Source DB:  PubMed          Journal:  Cell Host Microbe        ISSN: 1931-3128            Impact factor:   21.023


  51 in total

1.  Type-I IFN drives the differentiation of short-lived effector CD8+ T cells in vivo.

Authors:  Melanie Wiesel; Josh Crouse; Gregor Bedenikovic; Andrew Sutherland; Nicole Joller; Annette Oxenius
Journal:  Eur J Immunol       Date:  2011-12-20       Impact factor: 5.532

2.  Tolerance induction in double specific T-cell receptor transgenic mice varies with antigen.

Authors:  H Pircher; K Bürki; R Lang; H Hengartner; R M Zinkernagel
Journal:  Nature       Date:  1989-11-30       Impact factor: 49.962

3.  Toll-like receptor (TLR) expression on CD4+ and CD8+ T-cells in patients chronically infected with hepatitis C virus.

Authors:  Talia Hammond; Silvia Lee; Mark W Watson; James P Flexman; Wendy Cheng; Sonia Fernandez; Patricia Price
Journal:  Cell Immunol       Date:  2010-06-08       Impact factor: 4.868

4.  CD4+ T cells are required to sustain CD8+ cytotoxic T-cell responses during chronic viral infection.

Authors:  M Matloubian; R J Concepcion; R Ahmed
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

Review 5.  Modulation of dendritic cell function by persistent viruses.

Authors:  Bisheng Liu; Andrea M Woltman; Harry L A Janssen; Andre Boonstra
Journal:  J Leukoc Biol       Date:  2008-09-25       Impact factor: 4.962

6.  Imiquimod, a Toll-like receptor-7 agonist, induces perforin in cytotoxic T lymphocytes in vitro.

Authors:  Andreas Ambach; Bernd Bonnekoh; Myhan Nguyen; Michael P Schön; Harald Gollnick
Journal:  Mol Immunol       Date:  2004-04       Impact factor: 4.407

7.  Antiviral defense in mice lacking both alpha/beta and gamma interferon receptors.

Authors:  M F van den Broek; U Müller; S Huang; M Aguet; R M Zinkernagel
Journal:  J Virol       Date:  1995-08       Impact factor: 5.103

8.  CD4 T cell control primary measles virus infection of the CNS: regulation is dependent on combined activity with either CD8 T cells or with B cells: CD4, CD8 or B cells alone are ineffective.

Authors:  Antoinette Tishon; Hanna Lewicki; Abegail Andaya; Dorian McGavern; Lee Martin; Michael B A Oldstone
Journal:  Virology       Date:  2006-03-10       Impact factor: 3.616

9.  Coregulation of CD8+ T cell exhaustion by multiple inhibitory receptors during chronic viral infection.

Authors:  Shawn D Blackburn; Haina Shin; W Nicholas Haining; Tao Zou; Creg J Workman; Antonio Polley; Michael R Betts; Gordon J Freeman; Dario A A Vignali; E John Wherry
Journal:  Nat Immunol       Date:  2008-11-30       Impact factor: 25.606

10.  Impaired antibody response causes persistence of prototypic T cell-contained virus.

Authors:  Andreas Bergthaler; Lukas Flatz; Admar Verschoor; Ahmed N Hegazy; Martin Holdener; Katja Fink; Bruno Eschli; Doron Merkler; Rami Sommerstein; Edit Horvath; Marylise Fernandez; André Fitsche; Beatrice M Senn; J Sjef Verbeek; Bernhard Odermatt; Claire-Anne Siegrist; Daniel D Pinschewer
Journal:  PLoS Biol       Date:  2009-04-07       Impact factor: 8.029

View more
  37 in total

1.  Lymphocytic Choriomeningitis Virus Differentially Affects the Virus-Induced Type I Interferon Response and Mitochondrial Apoptosis Mediated by RIG-I/MAVS.

Authors:  Christelle Pythoud; Sylvia Rothenberger; Luis Martínez-Sobrido; Juan Carlos de la Torre; Stefan Kunz
Journal:  J Virol       Date:  2015-04-01       Impact factor: 5.103

2.  Silica exposure and chronic virus infection synergistically promote lupus-like systemic autoimmunity in mice with low genetic predisposition.

Authors:  Rosana Gonzalez-Quintial; Jessica M Mayeux; Dwight H Kono; Argyrios N Theofilopoulos; Kenneth M Pollard; Roberto Baccala
Journal:  Clin Immunol       Date:  2019-06-05       Impact factor: 3.969

3.  Platelet-TLR7 mediates host survival and platelet count during viral infection in the absence of platelet-dependent thrombosis.

Authors:  Milka Koupenova; Olga Vitseva; Christopher R MacKay; Lea M Beaulieu; Emelia J Benjamin; Eric Mick; Evelyn A Kurt-Jones; Katya Ravid; Jane E Freedman
Journal:  Blood       Date:  2014-04-22       Impact factor: 22.113

4.  Type I interferon is a therapeutic target for virus-induced lethal vascular damage.

Authors:  Roberto Baccala; Megan J Welch; Rosana Gonzalez-Quintial; Kevin B Walsh; John R Teijaro; Anthony Nguyen; Cherie T Ng; Brian M Sullivan; Alessandro Zarpellon; Zaverio M Ruggeri; Juan Carlos de la Torre; Argyrios N Theofilopoulos; Michael B A Oldstone
Journal:  Proc Natl Acad Sci U S A       Date:  2014-06-02       Impact factor: 11.205

Review 5.  A development that may evolve into a revolution in medicine: mRNA as the basis for novel, nucleotide-based vaccines and drugs.

Authors:  Karl-Josef Kallen; Andreas Theß
Journal:  Ther Adv Vaccines       Date:  2014-01

6.  Critical role for interferon regulatory factor 3 (IRF-3) and IRF-7 in type I interferon-mediated control of murine norovirus replication.

Authors:  Larissa B Thackray; Erning Duan; Helen M Lazear; Amal Kambal; Robert D Schreiber; Michael S Diamond; Herbert W Virgin
Journal:  J Virol       Date:  2012-10-03       Impact factor: 5.103

7.  Is the TAM receptor Axl a receptor for lymphocytic choriomeningitis virus?

Authors:  Brian M Sullivan; Megan J Welch; Greg Lemke; Michael B A Oldstone
Journal:  J Virol       Date:  2013-01-16       Impact factor: 5.103

Review 8.  Germinal centers and autoimmune disease in humans and mice.

Authors:  Anthony L DeFranco
Journal:  Immunol Cell Biol       Date:  2016-08-26       Impact factor: 5.126

9.  Hematopoietic and nonhematopoietic cells promote Type I interferon- and TLR7-dependent monocytosis during low-dose LCMV infection.

Authors:  Matthew B Buechler; Griffin M Gessay; Shivani Srivastava; Daniel J Campbell; Jessica A Hamerman
Journal:  Eur J Immunol       Date:  2015-09-14       Impact factor: 5.532

10.  Pathogenesis of Lassa fever virus infection: I. Susceptibility of mice to recombinant Lassa Gp/LCMV chimeric virus.

Authors:  Andrew M Lee; Justin Cruite; Megan J Welch; Brian Sullivan; Michael B A Oldstone
Journal:  Virology       Date:  2013-05-16       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.